drugset / Trial / NCT02655198
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NaSingle-groupOpen-labelTreatment
Summary
In this trial, the potential anti-epileptic effect of low dose fenfluramine in Lennox Gastaut epilepsy will be studied. An exploratory dose finding add-on trial is proposed. At baseline and at the end of the study, ECG and ultrasound of the heart will be performed as part of the safety follow up.
Timeline
- Start
- 2016-01
- Primary completion
- 2018-09
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenfluramine | Small molecule | 0.2 mg/kg | Oral |
| Subject | Fenfluramine | Small molecule | 0.4 mg/kg | Oral |
| Subject | Fenfluramine | Small molecule | 0.8 mg/kg | Oral |